Richard Freed Email

CEO . RheumaGen

Current Roles

Employees:
7
Revenue:
$1.1M
About
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com. \n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
RheumaGen Address

Denver, CO
United States
RheumaGen Email